The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus

Author： De La Cruz J.P.   Moreno A.   Merida F.   Campos J.G.   de la Cuesta F.S.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.81, Iss.3, 1996-02, pp. : 327-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erectile Dysfunction and Diabetes Mellitus: Mechanistic Considerations from Studies in Experimental Models

By  

Current Diabetes Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. : 149-158

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives

By  

Current Vascular Pharmacology, Vol. 10, Iss. 1, 2012-01 ,pp. : 19-32

Bentham Science Publishers

Access to resources Recommend Favorite

Review of the Relationship between Renal and Retinal Microangiopathy in Diabetes Mellitus Patients

By  

Current Diabetes Reviews, Vol. 6, Iss. 2, 2010-03 ,pp. : 88-101

Bentham Science Publishers

Access to resources Recommend Favorite

Weight Effect of Current and Experimental Drugs for Diabetes Mellitus: From Promotion to Alleviation of Obesity

By Purnell J.Q.  

Treatments in Endocrinology, Vol. 2, Iss. 1, 2003-01 ,pp. : 33-47

Adis International

Access to resources Recommend Favorite

Effect of DT-TX 30, a Combined Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, on Retinal Vascularity in Experimental Diabetes Mellitus - A novel device for assessing platelet behavior in blood

By De La Cruz J.P.   Moreno A.   Ruiz-Ruiz M.I.   De La Cuesta F.S.  

Thrombosis Research, Vol. 97, Iss. 3, 2000-02 ,pp. : 125-131

Elsevier

Access to resources Recommend Favorite